Anuj Shrestha

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 105 citations · Full text

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Rachel Yoder, Bruce F. Kimler, Joshua M. Staley et al. · npj Breast Cancer · 2022 · 67 citations · Full text

Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China

Hai‐Jie Hu, Yanwen Jin, Anuj Shrestha et al. · Cancer Medicine · 2019 · 48 citations · Full text

Selective histology of cholecystectomy specimens—is it justified?

Yilei Deng, Xianze Xiong, Yong Zhou et al. · Journal of Surgical Research · 2014 · 37 citations

Biliary Tract, Surgical Pathology, Histopathology +4

Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?

Jun-Ke Wang, Hai‐Jie Hu, Anuj Shrestha et al. · Oncotarget · 2017 · 37 citations · Full text